Transplant Diagnostics Market

Transplant Diagnostics Market Size, Share & Trends

The size of global transplant diagnostics market in terms of revenue was estimated to be worth $4.4 billion in 2022 and is poised to reach $6.8 billion by 2028, growing at a CAGR of 7.4% from 2022 to 2028. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

Increased impact of infectious diseases. The number of people with end-stage organ failure has been rising, and due to advancements in transplantation, a larger percentage of  people are now eligible for organ transplantation. This growing need is a result of these two factors. Increasing public and private funding for transplantation and various organ transplant awareness campaigns.

Transplant Diagnostics Market Trends

To know about the assumptions considered for the study, Request for Free Sample Report

e- Estimated; p- Projected

Transplant Diagnostics Market Dynamics

Driver: Increasing number of transplant procedures.

The rising adoption of several technologies and screening tests, genomic profiling and cross-matching are making transplants a suitable way of giving life or rebirth of the individual. The rising number of transplant procedures across major countries can be attributed to the rising CAGR of the transplant market. For instance, in the U.S 41,354 organ transplants were carried out in 2021, France 5,273 organ transplants in 2021. Diseases such as TB, end-stage renal diseases and liver cirrhosis are common among geriatric individuals and it makes it a compulsion for the individual to undergo transplant surgery.

Opportunity: Growing public awareness about organ donation and transplantation.

In 2022, the American Transplant foundation organized a fundraising event namely DLA Awards to support programs that promote public awareness related to organ donations and transplantations In 2021, the Organ receiving and giving awareness network (India) conducted an awareness program that aimed to strengthen public willingness to donate organs for transplantation procedures in India.In US long runs of 3kms,5kms and 10kms are organized to promote organ transplants within the public and make them aware of the necessity of giving life to others.

Challenge: Significant gap between number of organs donors and organs required.

There is a significant gap between number of organs donated annually and number of organs donations required. The limited number of organs donated annually across the globe is primarily due to strict government enforcement and limited medical reimbursements for living organ donors and lack of awareness about organ donations.

Restraint: High procedural cost of NGS and PCR-based diagnostic assays

Transplant diagnostic procedures for Histocompatibility tests,blood profiling,genomic profiling are conducted through specialized molecular diagnostic platforms that consists of several advanced technologies. These technologies are integrated with conventional PCR/NGS instruments and thus the cost of these advanced products is on the higher edge.

Market Ecosystem

By technology, the molecular assay technologies segment accounted for the largest share of the transplant diagnostics market during the forecast period.

In 2022, molecular assay technologies accounted for the largest share of in the market. This segment is projected to reach USD 6,156.9 million in 2028 from USD 4,166.0 in 2022, at a CAGR of 8.0% during the forecast period. Molecular assays are used in transplant diagnostic procedures for donor-recipient compatibility testing. The growing demand for molecular assays during transplant diagnostic procedures is mainly attributed to the technological benefits offered by these assays as compared to non-molecular assays, such as high procedural efficacy, the study of multiple samples and real time analysis.

By End User, Independent reference laboratories is expected to grow at the fastest rate in the transplant diagnostics market during the forecast period.

In 2022, Independent reference laboratories hold a larger share In the market with a share of 58.65%. This end-user segment is projected to reach USD 4,233.9 in 2028 from USD 2,668.8 in 2022. This end-user segment is also expected to grow at the highest CAGR of 8.0% during the forecast period. The large share of this segment can be attributed to the rapid modernization and automation of diagnostic laboratories and growing number of research and developmental activities.

By Product & Services, the Reagents & Consumables segment holds the largest share of the transplant diagnostics market.

In 2022, Reagents & Consumables holds the largest around 72.2% in the market. This Product & Service segment is projected to reach USD 5,131.0 million in 2028 from USD 3,265.2 million in 2022. Reagents & consumables account for the largest share of transplant diagnostics. Expansion in the application horizons of molecular assay techniques in transplant diagnostics, increasing patient emphasis on effective and early patient profiling during organ transplantation.

By Application, Infectious disease testing accounted for the largest share of the transplant diagnostics market during the forecast period.

In 2022, Infectious disease testing is projected to reach USD 3,764.3 million in 2028 from USD 2,344.0 million in 2022.A number of factors, such as ongoing technological advancements in the field of molecular assay techniques, the increasing adoption of these techniques for pathogen detection and histocompatibility testing and the rising incidence of infectious chronic diseases is helping this segment to grow at a high CAGR.

North America is expected to be the largest region in the transplant diagnostics market during the forecast period.

North America, comprising the US and Canada, accounted for the largest share of 45.4% of the market in 2022. Factors such as the high prevalence of diseases, the rising geriatric population, emergence of infectious diseases is contributing to the large share of North America.

APAC region is growing at the highest CAGR of 8.3% due to increasing organ donations and various public and private reimbursements policies.

To know about the assumptions considered for the study, download the pdf brochure

As of 2021, prominent players in the market are include bioMérieux SA (France), Becton, Dickinson, and Company (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc. (US) among others.

Transplant Diagnostics Market Report Scope:

This report categorizes the global transplant diagnostics market into following segments & sub-segments:

By Technology

• Molecular assay technologies
  • PCR-based molecular assays
  • Real-time PCR
  • Sequence-specific primer-PCR
  • Sequence-specific Oligonucleotide-PCR
  • Other PCR-based molecular assays
• Sequencing based molecular assays
  • Sanger sequencing
  • Next generation sequencing
  • Other sequencing based molecular assays
• Non molecular assays technologies

By Product & Service

• Reagents & Consumables
• Instruments
• Software & Services

By Application

• Diagnostic application
  • Pre-transplantation Diagnostics
    • Infectious Disease testing
    • Histocompatibility testing
    • Blood profiling
  • Post -transplantation Diagnostics
• Research applications

By transplant type

• Solid Organ Transplantation
  • Kidney transplantation
  • Liver transplantation
  • Heart transplantation
  • Lung transplantation
  • Pancrease transplantation
  • Other Organs transplantation
• Stem Cell transplantation
• Soft tissue transplantation
• Bone marrow transplantation

By End User

• Hospitals and Transplant centers
• Research &Academic Institutes
• Independent reference laboratories

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

Recent Developments

• In February 2023, BD received FDA approval for BD Onclarity HPV assay in the serology testing segment
• In March 2023 BioRad received AQAC International and AFNOR approval for its iQ-Check kits.
• Hoffmann-La Roche Ltd. unveiled Cobas Infinity edge, a cloud-based point-of-care platform that is available everywhere, in January 2022. Practitioners in the healthcare industry can manage patient data thanks to advanced technology. This has aided the business in diversifying its product offering.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst